It is the vision and declared objective of IGradU to train PhD and MD students in an international context and to the highest standards in order to strengthen the scientific performance of Ulm University in the field of Molecular Medicine and to further develop its national and international reputation.

Externally Funded Research Training Groups

  • GRK 1789 Cellular and Molecular Mechanisms in Aging

    (Speaker: Prof. Dr. Hartmut Geiger, Department of Dermatology and Allergology)

    CEMMA is a research training program for graduate students with a focus on aging research. Demographic development has led to the prediction of a significant increase in age-associated diseases. Thus, age-associated diseases and their prevention will become one central aspect of medicine, business and social studies. An improved and in-depth knowledge of the basic molecular and cellular mechanisms of aging will allow the formulation of rational approaches and therapies that are ultimately aimed at achieving healthy aging. The research training program, Cellular and Molecular Mechanisms in Aging (CEMMA), will recruit and train the next generation of scientists in aging research and this will be a very critical task in light of anticipated demographic developments. The qualification program in the field of aging research includes specific teaching modules centered on model systems in aging research and on the theories of molecular aging. In addition, there are also modules analyzing aging with respect to general medicine and social studies. Research projects within CEMMA focus on aging and cancer, stem cells, DNA-repair, age-related changes in immune cells, and inflammation and neurodegenerative diseases.

    Please follow the link for further information on CEMMA



  • Pharmaceutical Biotechnology (PBT)

    (Speakers: Prof. Dr. Peter Dürre, Institute of Microbiology and Biotechnology; Prof. Dr. Jürgen Hannemann, University of Applied Sciences in Biberach)

    The region around Ulm is the second largest pharmaceutical industrial area within Germany. Prominent members are Boehringer Ingelheim Pharma GmbH in Biberach, Rentschler Biotechnologie GmbH in Laupheim, and Ratiopharm/Teva Pharmaceutical Industries in Ulm. The field of Pharmaceutical Biotechnology is an interdisciplinary research topic both in natural science and in medicine and is therefore optimally suited for a cross-university cooperative PhD training group. The cooperative PhD training group includes research projects which cover the whole value added chain in the field of pharmaceutical biotechnology. Through a specifically designed program, PBT makes possible a highly specialized degree that allows intensive cooperation and an interlinking of the two universities in the field of the life sciences. The PhD-training group of Ulm/Biberach is one of eight cooperative PhD training groups being funded by the State of Baden-Württemberg. Scholarship holders are chosen based on a common selection procedure with the International Graduate School in Molecular Medicine Ulm and participate in its program. There are currently five PhD-students taking part in this cooperative PhD training course.